Sign in
Year 1 Time to Mobility Test Completion in a Voretigene Neparvovec-rzyl Trial in Subjects With RPE65 Mutation–Associated Inherited Retinal Disease
Julia A. Haller, MD
On Demand Cases, Courses, and Papers
2018
6-Month Results of a Phase 1b-2 Prospective Multicenter Clinical Trial of a Novel Targeted Therapy (AU-011) for the Treatment of Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Category: Diabetic Retinopathy